Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
166 Leser
Artikel bewerten:
(0)

India-Based Pharmaceutical Companies See Growing Need for Focused Medical Affairs Functions

CHAPEL HILL, N.C., Jan. 3, 2014 /PRNewswire/ --Across the global healthcare landscape, the Medical Affairs function is essential for meeting a variety of challenges. Successful Medical Affairs groups often thrive because their organization realizes that they provide extremely valuable services. Despite this, groups within the Indian Pharmaceutical industry are still rapidly evolving and are struggling to show the value of their Medical Affairs functions.

Medical Affairs continues to grow into a global function, with emerging markets increasingly seeing the need for and importance of focused Medical Affairs functions. Recent research from benchmarking firm, Best Practices, LLC even found that 89% of Indian benchmarked companies now have a dedicated Medical Affairs group in their organization. As the healthcare environment becomes increasingly competitive, the role of Medical Affairs in India will become more and more critical.

The report, "Building Best-in-Class Medical Affairs Capabilities In India- A Case Study For High-Growth Emerging Markets," provides leaders with comparative metrics, executive insights, and best practices from Medical Affairs professionals throughout the industry. The research also illustrates how leading Global and Indian pharmaceutical and medical device companies structure and organize their Medical Affairs functions.

Key study topics include:

  • Medical Affairs Scope & Structure
  • Leadership & Oversight
  • Regulatory Landscape & Challenges
  • Spend Allocations & Investment Benchmarks
  • Staffing Benchmarks
  • Functional Responsibility & Service
  • Budget Trends & Success Factors

This benchmarking research drew participation from 68 benchmark survey respondents from 50 companies. In addition, research analysts conducted in-depth interviews with 7 respondents to collect qualitative data and insights.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link:http://www.best-in-class.com/rr1258.htm.

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.